期刊文献+

嫌色细胞肾细胞癌和肾嗜酸细胞腺瘤CD117的表达及意义 被引量:6

CD117 expression in chromophobe renal cell carcinoma and renal oncocytoma and its significance
下载PDF
导出
摘要 目的研究CD117在肾上皮性肿瘤中的表达。方法采用免疫组织化学方法,观察33例嫌色细胞肾细胞癌(RCC)、10例肾嗜酸细胞腺瘤、151例透明细胞RCC、33例乳头状RCC和3例黏液管状梭形细胞癌组织中CD117的表达。结果33例嫌色细胞RCC中,29例(87.9%)CD117阳性;10例肾嗜酸细胞腺瘤中,9例CD117阳性;透明细胞RCC、乳头状RCC和黏液管状梭形细胞癌中均未见CD117表达。结论CD117高表达是嫌色细胞RCC和肾嗜酸细胞腺瘤的特征之一,CD117免疫组织化学染色结果有助于肾上皮性肿瘤的鉴别诊断。 Objective To study the expression of CD117 in renal epithelial neoplasms. Methods CD117 expression was observed in 33 cases of chromophobe renal cell carcinoma (RCC), 10 cases of renal oncocytoma, 151 cases of clear cell RCC, 33 cases of papillary RCC, and 3 cases of nucinous tubular and spindle cell carcinoma using Envision immunohistochemistry. Results Positive expression of CDl17 was observed in 29 of 33 cases (87.9%) with chromophobe RCC tissues and 9 with 10 cases with renal oncocytoma tissues. No CD117 overexpression was observed in clear cell RCC, papillary RCC or mucinous tubular and spindle cell carcinoma tissues. Conclusion High expression of CD117 is one of the characteristics of chromophobe RCC and renal oncocytoma; immunohistochemistry detection of CD117 may helpful for differential diagnosis of renal epithelial cell neoplasms.
出处 《上海医学》 CAS CSCD 北大核心 2009年第8期731-733,F0004,共4页 Shanghai Medical Journal
关键词 CD117 肾细胞癌 肾嗜酸细胞腺瘤 CD117 Renal cell carcinoma Renal oncocytoma
  • 相关文献

参考文献3

二级参考文献11

  • 1黄文斌,陈洁宇,周晓军.KIT和RCC在肾嫌色细胞癌和透明细胞癌颗粒细胞亚型中鉴别诊断中的价值[J].临床与实验病理学杂志,2005,21(4):429-429. 被引量:13
  • 2刘强,朱建善,许燕萍,林鸿翔.AMACR和CK7表达在乳头状肾细胞癌诊断中的意义[J].上海第二医科大学学报,2005,25(9):947-950. 被引量:3
  • 3饶秋,周晓军.免疫组织化学在肾脏肿瘤病理诊断中的应用[J].中华病理学杂志,2006,35(4):244-247. 被引量:19
  • 4Eble JN, Sauter G, Epstein JI, et al. World Health Organization classification of tumors. Pathology & genetics of tumors of the urinary system and male genital organs [M]. Lyon: IARC Press, 2004.12 - 43.
  • 5Mazal PR, Exner M, Haitel A, et al. Expression of kidney-specific cadherin distinguishes chromophobe renal cell carcinoma from renal oncocytoma [J]. Hum Pathol, 2005,36 ( 1 ) : 22 - 28.
  • 6Tretiakova MS, Sahoo S, Tadahashi M, et al. Expression of alphamethylacyl-CoA racemase in papillary renal cell carcinoma[J]. Am J Stag Pathol, 2004,28(1):69 - 76.
  • 7Pan CC, Chen PC, Ho DM. The diagnostic utility of MOC31, BerEP4, RCC marker and CD10 in the classification of renal cell carcinoma and renal oncocytoma: an immunohistochemical analysis of 328 cases [J]. Histopathology, 2004,45 (5) : 452 - 459.
  • 8Skinnider BF, Folpe AL, Hennigar RA, et al. Distribution of cytokeratins and vimentin in aduh renal neoplasras and normal renal tissue: potential utility of a cytokeratin antibody panel in the differential diagnosis of renal tumors[J]. Am J Stag Pathol,2005,29 (6) :747 - 754.
  • 9Langner C, Wegscheider BJ, Ratschek M, et al. Keratin immunohistochemistry in renal cell carcinoma subtypes and renal oncocytomas: a systematic analysis of 233 tumors[J]. Virchows Arch, 2004,444(2): 127 - 134.
  • 10Mathers ME, Pollock AM, Marsh C, et al. Cytokeratin 7: a useful adjunct in diagnosis of chromophobe renal cell carcinoma [J]. Histopathology,2002,40(6) :563 - 567.

共引文献36

同被引文献83

引证文献6

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部